Latest

• Cefpodoxime proxetil – new opportunities in antibacterial therapy of respiratory infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(4):366-371

• Oral third-generation cephalosporin cefpodoxime in the therapy of respiratory infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(3):266-276

• Microbiologic diagnosis of community-acquired urinary tract infections: official statements of the board of experts

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(3):221-224

• The known-unknown: third- and fourth-generation cephalosporins combined with sulbactam

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):41-55

• Probiotics: controversial issues

  Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(4):345-360

• Psychobiotics: a new way in psychopharmacology, or How do bacteria manage our brain?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(2):108-133

• Pneumococcal vaccination in adult patients with comorbidities: a review of the clinical practice guidelines

  Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(4):254-265

• Gastrointestinal adverse drug reactions and antibiotic-associated diarrhea during antibiotic therapy in outpatient practice: prevention and treatment

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(3):196-206

• The evidence base and practical approaches to probiotic use in clinical practice: a focus on Lactobacillus rhamnosus GG and Bifidobacterium lactis Вb-12

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2):100-118

• New probiotic strain Streptococcus salivarius K12 in clinical practice

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2):92-99

• Current approaches to prophylaxis and treatment of travelers’ diarrhea

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(3):172-180

• Ceftazidime-avibactam: new rules for the game against multidrug-resistant gram-negative bacteria

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):24-34

• Antibiotic dosing in obesity: size does matter?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(3):214-228

• Efficacy and Safety of Lactobacillus acidophilus LA-5 and Bifidobacterium lactis BB-12 Combination in Gastroenterology, Pediatrics and Allergology

  Clinical Microbiology and Antimicrobial Chemotherapy. 2016; 18(2):113-124

• Analysis of Antibiotic Usage in Children Living in Orphanages During the 2003–2004 and 2009–2010

  Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(4):286-294

• Treatment of Acute Tonsillitis/Pharyngitis: Current Guidelines and Russian Local Situation

  Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(3):198-211

• Review of Current Guidelines on the Management of Pediatric Patients with Acute Bacterial Rhinosinusitis

  Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(3):176-190

• Safety and Efficacy of Antibiotics Used in Outpatient Setting

  Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(1):67-84

• Approaches to Diagnosis and Treatment of Acute Male Urethritis: Results of Multicenter Observational Study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(1):19-39

• Selection of Macrolide Resistance

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(3):255-259

• Strain-specific Effects of Probiotics

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(3):253-254

• Clinical Perspectives of Tigecycline

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(2):127-145

• Hospital-Acquired Pneumonia in Trauma Patients: Results of Prospective Observational Study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(2):106-116

• Common Questions About the Treatment of Community-Acquired Pneumonia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(1):82-85

• Emerging Concepts in Use of Macrolides in Pregnancy and Lactation

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(1):41-53

• Potential for Use of Spiramycin in Clinical Practice

  Клиническая Микробиология и Антимикробная Химиотерапия. 2009; 11(3):218-238

• Respiratory Tract Infections: New View on the Old Problem

  Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(2):143-151

• Meropenem in the Treatment of Severe Infections in Children

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):322-332

• Doripenem: a New Carbapenem Antimicrobial

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(3):245-259

• Pneumonia in Nursing Homes: Current View on Problem

  Clinical Microbiology and Antimicrobial Chemotherapy. 2007; 9(1):4-19

• Comparison of Results of Antimicrobial Susceptibility Testing of Gram-negative Aerobic Bacteria by Disc Diffusion on Mueller-Hinton Agar and AGV Medium

  Clinical Microbiology and Antimicrobial Chemotherapy. 2004; 6(2):155-167

• Comparative Activity of Cefepime and Other Antimicrobials Against Nosocomial Gram-Negative Pathogens in Russia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(3):259-274

• Practice Guidelines on Antimicrobial Therapy of Sinusitis

  Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(2):167-174

• Comparative Activity of Antipseudomonal Antibiotics Against Nosocomial Strains of P. aeruginosa in Russian ICUs

  Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(1):35-46

• Recommendations on the Optimization of Antimicrobial Chemotherapy of Nosocomial Infections Caused by GramdNegative Bacteria in Intensive Care Units (Guidelines for clinicians)

  Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(4):379-390

• Resultst of the Multicentre study of Nasopharyngeal Isolates of Haemophilus influenzae from Healthy Children in Day-Care Centers

  Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(1):33-41

• Specificities of The Susceptibility Testing by Disk-Diffusion Method

  Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(4):348-354

• Susceptibility to antimicrobials of pneumococci isolated from healthy children from organised collectives

  Clinical Microbiology and Antimicrobial Chemotherapy. 1999; 1(1):31-39